MedPath

A novel drug to treat gum diseases.

Phase 2
Completed
Conditions
Other infectious disease,
Registration Number
CTRI/2019/05/019477
Lead Sponsor
Dayananda Sagar College of Dental Sciences
Brief Summary

A split mouth study was conducted wherein 29 patients were selected and the results obtained with local drug delivery were compared with those obtained with those obtained with scaling and root planing.Scaling and root planing is the commonly employed procedure for the treatment of periodontal diseases.However tissue invasive bacteria may still be present and harboring the periodontal tissues.Hence the use of adjunctive antimicrobial therapy is advised.There are many commercially available agents for local drug delivery but are associated with disadvantages like antimicrobial resistance, lack of substantivity etc. Chitosan is a drug which once administered will exhibit its effect for extended period of time and hence iwas tried against the periodontal pathogens

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
29
Inclusion Criteria
  • Probing pocket depth 5mm to 8mm.
  • Clinical attachment level of 3mm.
  • Vertical bone loss greater than 3mm on digital radiographs.
Exclusion Criteria
  • Patients with systemic diseases.
  • Patients who have undergone periodontal treatment in last 6 months.
  • Pregnant and lactating mothers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the antimicrobial efficacy of Chitosan nanoparticle gel (1%) as local drug delivery against periopathogens Porphyromonas gingivalis, Tanerella forsythia.6 weeks interval
Secondary Outcome Measures
NameTimeMethod
Gingival index,plaque index,6 week interval

Trial Locations

Locations (1)

Dayananda Sagar College of Dental Sciences

🇮🇳

Bangalore, KARNATAKA, India

Dayananda Sagar College of Dental Sciences
🇮🇳Bangalore, KARNATAKA, India
NageswaranGR
Principal investigator
8098821190
g.nageswaran61@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.